Clinical Trials on Liver Cirrhosis, Biliary in Hong Kong

Total 503 results

Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

HCV Infection

Hong Kong
The University of Hong Kong

Unknown

A Prospective Randomized Controlled Trial on the Use of Cerebral Oximetry in Adult Chinese Patients Undergoing Liver Transplantation (LT)

Liver Failure

Hong Kong, China
Chinese University of Hong Kong

Terminated

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

Non-alcoholic Fatty Liver Disease

Hong Kong
Chinese University of Hong Kong

Completed

Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease

Obstructive Sleep Apnea | Non-alcoholic Fatty Liver Disease

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Hong Kong Children's Hospital

Recruiting

Ultrasound Measurements of Hepatic Vasculatures and Hepatic Doppler Assessment of Healthy Children

Portal Vein | Hepatic Veins | Hepatic Artery | Liver Circulation

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC)_Torisel_

Inoperable HCC

Hong Kong
The University of Hong Kong

Completed

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Secondary

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. (EGDB)

Acute Cholecystitis

China
Chinese University of Hong Kong

Terminated

Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Chronic Hepatitis B

Hong Kong
CCTU

Recruiting

Pembrolizumab in Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

TACE Emulsion Versus Suspension

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Completed

SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong

Unknown

SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Completed

Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease

China
The University of Hong Kong

Completed

Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

Hepatocellular Carcinoma Non-resectable | Stereotactic Body Radiotherapy

Hong Kong
Chinese University of Hong Kong

Completed

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers (PDT)

Cholangiocarcinoma | Klatskin Tumor | Tumor

Hong Kong
Humanity and Health Research Centre

Recruiting

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Chronic Hepatitis B | Nonalcoholic Fatty Liver Disease

China
The University of Hong Kong

Completed

Optimizing HBV Management During Anti-CD20 Antibodies

Hepatitis B | Liver Dysfunction | Immune Suppression

Hong Kong
Chinese University of Hong Kong

Completed

Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Recruiting

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Diabetes Mellitus | Insulin Resistance | Obesity, Morbid | Non-Alcoholic Fatty Liver Disease | Metabolic Disease | Brown Fat | Abdominal Subcutaneous Fat

Hong Kong
The University of Hong Kong

Recruiting

Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc) (OBI)

Liver Transplant; Complications | Occult Hepatitis B

Hong Kong
Aegera Therapeutics
Chinese University of Hong Kong

Completed

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Terminated

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Zai Lab (Shanghai) Co., Ltd.

Terminated

MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients

Advanced Hepatocellular Carcinoma (HCC)

China
Chinese University of Hong Kong

Recruiting

Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function

Carcinoma, Hepatocellular

Hong Kong
Hospital Authority, Hong Kong
Schering-Plough

Unknown

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Carcinoma, Hepatocellular

China
Chinese University of Hong Kong

Recruiting

Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver

Hiv | NAFLD

Hong Kong
Chinese University of Hong Kong

Completed

Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

RCT on Adjuvant TACE After Hepatectomy for HCC (A-TECH)

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Completed

Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Recruiting

Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures

Biliary Stricture

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors (PDO)

Hepatocellular Carcinoma | Colorectal Cancer

Hong Kong
Chinese University of Hong Kong
Food and Health Bureau, Hong Kong

Unknown

A Clinical Trial of Electro-acupuncture for Treating Gallstone Diseases

Gallstones

China
Lee's Pharmaceutical Limited

Recruiting

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Advanced Hepatocellular Carcinoma

China
The University of Hong Kong
The Hong Kong Society of Nephrology

Unknown

Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients

Hepatorenal Syndrome

Hong Kong
The University of Hong Kong

Unknown

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (SECOX)

Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

China
Chinese University of Hong Kong
Tokyo University; Gifu University Graduate School of Medicine

Recruiting

Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy (ERVPP)

Bile Duct Diseases

Hong Kong

Clinical Trials on Liver Cirrhosis, Biliary in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations